2003, Number 2
<< Back Next >>
Rev Med Hosp Gen Mex 2003; 66 (2)
Paragangliomas of biologically malignant behavior. Study of two autopsy cases
Garduño JP, Durán MA, Chávez ML, Castro GL, Solís SV, Olvera RJE
Language: Spanish
References: 10
Page: 99-103
PDF size: 227.77 Kb.
ABSTRACT
Paragangliomas originate in the extraadrenal paraganglia of the neural crest which constitute the neuroendocrine system. Extraadrenal paragangliomas originate more frequently in the abdomen (85%), others in the thoracic region (12%), and more rarely, in the head and neck region (3%). Two post-mortem cases of paragangliomas are presented. The first case presented in a 60 year-old woman who had a clinical history of cephalea, bradypsychia and apraxia, she died of respiratory complications. The autopsy showed, gray-colored tumor was found at the pontocerebellar angle, which was shown to be a paraganglioma on microscopic and immunohistochemical examination. The second case presented in a 48 year-old man with a previous diagnosis of retroperitoneal paraganglioma, who died of a brain hemorrhage. At autopsy a solid white-gray tumor was found located on the right side of the abdominal aorta, with metastatic lesions in lung and liver. At the electronic examination, a paraganglioma was diagnosed, with corroborating findings at the ultrastructural level. There are no reliable means to distinguish between benign and malignant paragangliomas based only on its histopathological features. Invasion and metastatic disease are the factors that determine a malignant paraganglioma.
REFERENCES
Wasserman PG, Savargaonkar P. Paragangliomas: Classification, pathology, and differential diagnosis. Otolaryngol Clin North Am 2001; 34: 845-862.
Lack EE. Paragangliomas. In: Sternberg SS. Diagnostic surgical pathology. Lippincott Williams & Wilkins, 1999; 625-648.
Min KW. Diagnostic usefulness of sustentacular cells in paragangliomas: Immunocytochemical and ultrastructural investigation. Ultrastruct Pathol 1998; 22: 369-376.
Lee HJ, Barich F, Karnell LH et al. National Cancer Data Base report on malignant paragangliomas of the head and neck. Cancer 2002; 94: 730-737.
O´Riordian DS, Young WF Jr, Grant CS, Carney JA, Van Heerden JA. Clinical spectrum and outcome of functional extraadrenal paraganglioma. World J Surg 1996; 20: 916-921.
Scafani LM, Woodruff JM, Brennan MF. Extraadrenal retroperitoneal paragangliomas: natural history and response to treatment. Surgery 1990; 108: 1129-1130.
Hayes WS, Davidson AJ, Grimley PM et al. Extraadrenal retroperitoneal paraganglioma: clinical, pathologic, and CT findings. Am J Roentgenol 1990; 155: 1247-1250.
Linnoila RI, Keiser HR, Steinberg SM, Lack EE. Histopathology of benign versus malignant sympathoadrenal paraganglioma: clinicopathologic study of 120 cases including unusual histologic features. Hum Pathol 1990; 21: 1168-1180.
Linnoila RI, Lack EE, Steinberg SM, Keiser HR. Decreased expression of neuropeptides in malignant paragangliomas: An immunohistochemical study. Hum Pathol 1988; 19: 41-50.
Held EL, Gal AA, DeRose PB, Cohen C. Image cytometric nuclear DNA quantitation of paragangliomas in tissue sections. Prognostic significance. Anal Quant Cytol Histol 1997; 19: 501-506.